IRIS
GRAVINA, Antonietta Gerarda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.360
NA - Nord America 2.067
AS - Asia 391
SA - Sud America 13
AF - Africa 8
OC - Oceania 3
Totale 4.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.055
IE - Irlanda 792
IT - Italia 530
UA - Ucraina 247
GB - Regno Unito 237
CN - Cina 160
DE - Germania 148
SG - Singapore 130
FR - Francia 106
SE - Svezia 81
FI - Finlandia 76
GR - Grecia 48
TR - Turchia 43
PL - Polonia 24
VN - Vietnam 24
NL - Olanda 22
RU - Federazione Russa 16
BE - Belgio 15
IN - India 13
BR - Brasile 10
PK - Pakistan 10
CA - Canada 9
AT - Austria 8
IR - Iran 4
SN - Senegal 4
AU - Australia 3
CZ - Repubblica Ceca 3
MK - Macedonia 3
MX - Messico 3
ES - Italia 2
JP - Giappone 2
NG - Nigeria 2
AR - Argentina 1
BF - Burkina Faso 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
EC - Ecuador 1
ET - Etiopia 1
HK - Hong Kong 1
ID - Indonesia 1
KR - Corea 1
MY - Malesia 1
PH - Filippine 1
Totale 4.842
Salva come PNG Salva come JPEG
Città #
Dublin 789
Chandler 417
Jacksonville 376
Naples 123
Princeton 98
New York 86
Roxbury 79
Boardman 70
Ann Arbor 66
Singapore 62
Beijing 60
Cambridge 56
Bremen 53
Medford 48
Wilmington 44
Woodbridge 39
Caserta 30
Dong Ket 24
Kraków 24
Des Moines 23
Nanjing 22
San Mateo 20
Napoli 19
Mountain View 18
Paris 18
Amsterdam 16
Boydton 15
Brussels 15
Ashburn 13
Jinan 11
Lappeenranta 11
Shenyang 10
Angers 9
Milan 9
Rome 9
Atella 8
Sennori 8
Helsinki 7
Houston 7
Norwalk 7
Porto Alegre 7
Auburn Hills 6
Lahore 6
Seregno 6
Vienna 6
Aversa 5
Bacoli 5
Brighton 5
Lanzhou 5
Pomezia 5
St Petersburg 5
Cattolica 4
Hangzhou 4
Hyderabad 4
Lübeck 4
Mumbai 4
Munich 4
Salerno 4
Torre Annunziata 4
Atlanta 3
Bisaccia 3
Changsha 3
Düsseldorf 3
Gatchina 3
Guangzhou 3
Kunming 3
Lodi 3
Nanchang 3
Nola 3
Nuremberg 3
Panettieri 3
Portici 3
Seattle 3
Serino 3
Vasto 3
Arnhem 2
Berlin 2
Bologna 2
Brno 2
Buffalo 2
Casoria 2
Catania 2
Cesena 2
Changchun 2
Chicago 2
Civitavecchia 2
Colomiers 2
Erding 2
Forlì 2
Haikou 2
Hanover 2
Hebei 2
Jiaxing 2
Katsina 2
Kolkata 2
London 2
Los Angeles 2
Marano Di Napoli 2
Mexico 2
Miami 2
Totale 3.010
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 101
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 100
Intrafamilial spread of Helicobacter pylori infection 91
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 73
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 73
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 72
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 72
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 71
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 70
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 68
Apple polyphenols extract (APE) improves colon damage in a rat model of colitis 67
Caso di interferenza tra video capsula e pacemaker in paziente portatore di pacemaker per aritmia 66
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 65
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 64
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study. 63
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 63
The burden of anaemia in patients with inflammatory bowel diseases 63
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 63
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 61
Crohn’s disease and skin 60
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 60
Vascular endothelial growth factor and neo-angiogenesis in H. pylori gastritis in humans. 59
Efficacia di terapia quadruplice concomitante di cinque giorni per l’eradicazione dell’infezione dell’H. pylori in pazienti naive al trattamento. 59
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial 58
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 56
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 55
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 55
CARDIAC PACEMAKER AND WIRELESS CAPSULE ENDOSCOPY INTERFERENCE: CASE REPORT IN A PATIENT WITH GASTRIC VASCULAR ECTASIAS 55
Comparison of Timing to Develop Anti-Drug Antibodies to Infliximab and Adalimumab Between Adult and Pediatric Age Groups, Males and Females 55
L’utilizzo di farmaci anti-TNF nella Malattia di Crohn 54
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 54
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 53
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 52
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 51
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 49
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 49
Oral microbiota and salivary levels of oral pathogens in gastro‐intestinal diseases: Current knowledge and exploratory study 49
Diffusione intrafamiliare dell’infezione da Helicobacter pylori. 48
Infezione da Helicobacter pylori: fisiopatologia e clinica 48
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 48
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials 48
Prevalence of lesions detected at upper endoscopy: an Italian Survey. 47
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 47
Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments 46
Apple polyphenol extracts prevent aspirin-induced damage to the rat gastric mucosa 46
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 45
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 45
Levofloxacin-containing quadruple concomitant therapy for eradication of H. pylori infection. 44
Bone Alterations in Inflammatory Bowel Diseases: Role of Osteoprotegerin 44
Eradication of Helicobacter pylori infection: which regimen first? 43
Levofloxacin-based sequential therapy vs clarithromycin-based sequential therapy for eradication of H. pylori infection. 43
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection. 42
COELIAC DISEASE AND C VIRUS-RELATED CHRONIC HEPATITIS: A NON ASSOCIATION 42
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 42
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 40
Pyoderma gangrenosum: an updated review 39
The role of Helicobacter pylori infection and small intestinal bacterial overgrowth in rosacea 39
Secondary Extramedullary Plasmacytoma of the Duodenum: An Unusual Endoscopic Presentation 39
A randomized controlled trial of acarbose in hepatic encephalopathy 39
EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN’S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: A PROSPECTIVE OBSERVATIONAL REAL-LIFE STUDY 39
Cyclic vomiting in a young patient with superior mesenteric artery syndrome 38
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 38
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 38
Five-Day Quadruple Concomitant Therapy vs Ten-Day Sequential Therapy for Eradication of H. pylori Infection. 37
INTERFERENCE BETWEEN PACEMAKER AND VIDEO CAPUSLE ENDOSCOPY: CASE REPORT 37
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 37
Inflammatory Bowel Diseases: The Role of Gut Microbiota 37
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 37
Performance of a multi-compounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease 36
Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis 35
Telaprevir- or boceprevir-based triple-therapy in patients with HCV infection genotype 1: on-treatment efficacy and data on safety 35
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study 34
Light alcohol drinking and the risk of cancer development: a controversial relationship 34
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer 34
Erectile and sexual dysfunction in male and female patients with celiac disease: A cross-sectional observational study 34
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 33
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 33
Colonic angiodysplasia with adenomatous epithelial foci 32
Gastric xanthomatosis associated with gastric intestinal metaplasia in a dyspeptic patient 32
Fourteen-day, high-dose acid suppression, non-bismuth quadruple therapies (“hybrid” vs. “concomitant”) for Helicobacter pylori eradication: a randomised trial 32
Levofloxacin-based sequential therapy for eradication of H. pylori infection. 32
Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets 32
Cycloxygenase-2 and vascular endothelial growth factor expression in ileal pouch anal anastomosis. 31
Does gender influence upper gastrointestinal symptoms and endoscopic diagnosis? 31
Gender difference in dermatological adverse effects during antibodies anti-TNFα therapy in chronic inflammatory bowel disease 31
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 30
Five-day quadruple concomitant therpy vs ten-day sequential therapy for eradication of H. pylori infection. 30
Optimized non-bismuth quadruple therapies cure most patients infected with Helicobacter pylori despite resistance to Clarithromycin and Metronidazole 30
Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study 30
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 28
Prevalence of nonpolypoid colorectal neoplasia: an Italian multi center observational study 28
Second-Line Rescue Therapy With Moxifloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection 28
Studio della flora microbica intestinale 28
The “three-in-one” formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice 28
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 28
Fat: a matter of disturbance for the immune system 27
Helicobacter pylori and extragastric diseases: A review 27
Liver failure in an obese middle-aged woman after biliointestinal by pass 26
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 24
Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19 24
Totale 4.628
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.467
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020417 81 76 11 6 59 13 80 21 22 17 25 6
2020/2021638 58 10 67 36 90 13 86 58 15 88 75 42
2021/2022729 31 5 8 32 187 9 53 22 33 44 112 193
2022/20231.642 129 57 30 149 195 122 11 105 758 20 35 31
2023/2024907 56 37 43 62 231 110 26 17 7 40 95 183
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 5.041